Bank of Montreal’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-13,420
Closed -$72K 4402
2016
Q2
$72K Buy
13,420
+13,025
+3,297% +$66.8K ﹤0.01% 2938
2016
Q1
$2K Hold
395
﹤0.01% 4038
2015
Q4
$2K Sell
395
-29
-7% -$168 ﹤0.01% 4053
2015
Q3
$3K Buy
424
+29
+7% +$355 ﹤0.01% 3776
2015
Q2
$6K Hold
395
﹤0.01% 3616
2015
Q1
$4K Hold
395
﹤0.01% 3701
2014
Q4
$4K Buy
+395
New +$3.86K ﹤0.01% 3765
2014
Q3
Sell
-1,530
Closed -$18K 4971
2014
Q2
$18K Buy
+1,530
New +$13.9K ﹤0.01% 3656

Other funds holding RPTP

Bank of Montreal's RPTP Position: Q3 2016 in Review

Bank of Montreal sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q3 2016, closing a stake of 13,420 shares — an estimated $72K sold.

Bank of Montreal first reported a position in RPTP in Q2 2014 and held it in 8 quarters. The position peaked at $72K in Q2 2016. 111 funds tracked by Wall St. Rank hold RPTP as of Q3 2016.

  • Bank of Montreal reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Bank of Montreal sold 13,420 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q3 2016, an estimated $72K.
  • Bank of Montreal first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2014 and held it in 8 quarters.
  • Bank of Montreal's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $72K in Q2 2016.
  • 111 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q3 2016.

Based on Bank of Montreal's 13F filing for Q3 2016, filed 19 Oct 2016.